Ruah C B, Stram J R, Chasin W D
Department of Otolaryngology, New England Medical Center-Tufts University School of Medicine, Boston, MA 02111.
Arch Otolaryngol Head Neck Surg. 1988 Jun;114(6):671-5. doi: 10.1001/archotol.1988.01860180085037.
Recurrent aphthous stomatitis (RAS) is characterized by necrotizing ulcers of the oral mucosa that persist, remit, and recur for variable periods of time. Despite the benign nature of the disease, persistent pain and ulceration may disable patients from performing their daily activities. We describe three patients with long-standing active RAS treated with oral colchicine. All patients experienced a marked decrease in symptoms and a remission of the disease. Recurrences, however, occurred within three days of discontinuation of the therapy. In one patient, colchicine therapy was discontinued because of persistent diarrhea. In another, a second remission was more difficult to achieve on the same regimen. The literature on the subject is reviewed, and the beneficial effects of colchicine therapy are discussed in relation to the immunopathogenesis of this disease. We conclude that colchicine therapy should be considered as an alternative in the treatment of the major or persistent form of RAS.
复发性阿弗他口炎(RAS)的特征是口腔黏膜出现坏死性溃疡,这些溃疡会持续、缓解并在不同时间段内复发。尽管该疾病性质良性,但持续的疼痛和溃疡可能使患者无法进行日常活动。我们描述了三名长期患有活动性RAS的患者接受口服秋水仙碱治疗的情况。所有患者的症状均显著减轻,疾病得到缓解。然而,在治疗中断后的三天内复发就出现了。在一名患者中,由于持续腹泻而停用了秋水仙碱治疗。在另一名患者中,采用相同治疗方案更难实现第二次缓解。本文对该主题的文献进行了综述,并结合该疾病的免疫发病机制讨论了秋水仙碱治疗的有益效果。我们得出结论,秋水仙碱治疗应被视为治疗主要或持续性RAS形式的一种替代方法。